Memory Treatment Centers, a leader in neurocognitive disease care, is excited to be one of the first to administer the groundbreaking Alzheimer's medication, Kisunla (Donanemab)

Since last year, Memory Treatment Centers (MTC) has been a leading provider of the novel Alzheimer's treatment, Leqembi, providing hundreds of patients with the first-ever proactive approach to treating and preventing progression of the disease. Now, MTC continues to innovate in neurocognitive care by giving Alzheimer's disease (AD) patients additional treatment options. Through its national netwo...